Investor's Business Daily on MSN

Highly Watched TG Therapeutics Smashes Profit Views — But There's A Caveat

TG Therapeutics stock toppled early Monday on a key caveat that undercut the company's massive third-quarter profit beat.
Investor's Business Daily on MSN

TG Therapeutics Earns Membership In 95-Plus Composite Rating Club

TG Therapeutics earns the No. 5 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals ...